Quest's Focus Dx, Scripps Developing Plavix-Response Test for 3M Integrated Cycler
March 17, 2011
Quest's Focus Dx, Scripps Developing Plavix-Response Test for 3M Integrated Cycler
Focus and Quest are collaborating with clinical scientists from Scripps Translational Science Institute and Scripps Health to develop the test, which could eventually help clinicians personalize treatment with Plavix based on a patient's CYP2C19 genotype in less than an hour.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- PCR Probe Licensing Pact with Focus Diagnostics Portends 'Busy Year' for Evogen
March 14, 2013 / PCR Insider - Focus Diagnostics Awaits CE Mark, FDA Clearance for Combined Flu/RSV Test on 3M Instrument
August 26, 2010 / PCR Insider - Dx Focus: Focus Diagnostics' Simplexa Flu A/B & RSV Test
October 11, 2012 / PCR Insider - FDA Clears Focus Diagnostics' Flu Test on 3M Integrated Cycler
October 9, 2012 / GenomeWeb Daily News - Dx Focus: OraSure Gets FDA OK for DNA Collection Device; Quest Dengue Test Approved in Brazil
December 8, 2011 / PCR Insider